This report provides a summary of the key findings from the assessment of progress of the EU Member States, Norway and Turkey towards the implementation of the revised drug supply indicators, as developed by the EMCDDA in line with the Council conclusions of November 2013. The report gives also an overview of the purpose and aims of supply data collected by the EMCDDA.

Table of contents:
• Introduction
• Key events in the development of the revised and improved EU drug supply indicators
• Extent of implementation of data collection for the revised drug supply indicators
• Drug law offences (EMCDDA-Eurostat)
• Drug seizures
• Purity and potency of illicit substances
• Composition of illicit drug tablets
• Price of illicit substances
• Drug production monitoring tools (EMCDDA-Europol)
• Ongoing developmental work
• Conclusion
• References